{"nct_id":"NCT02494583","title":"Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)","status":"COMPLETED","status_verified_date":"2023-03","start_date":"2015-07-31","start_date_type":"ACTUAL","primary_completion_date":"2019-03-26","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}